Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mid-Day Market Update: Dow Falls 80 Points; Cellect Biotechnology Shares Spike Higher

GIC, TCRT, SEE, QNRX, GIII

Midway through trading Monday, the Dow traded down 0.39 percent to 20,515.95 while the NASDAQ fell 0.21 percent to 5,816.77. The S&P also fell, dropping 0.34 percent to 2,336.13.

Leading and Lagging Sectors
Healthcare shares rose by 0.53 percent on Monday. Meanwhile, top gainers in the sector included Impax Laboratories Inc (NASDAQ: IPXL), up 27 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), up 12 percent.

In trading on Monday, basic materials shares slipped by 0.68 percent. Meanwhile, top losers in the sector included Aluminum Corp. of China Limited (ADR) (NYSE: ACH), down 6 percent, and Sealed Air Corp (NYSE: SEE), off 5 percent.

Top Headline

G-III Apparel Group, Ltd. (NASDAQ: GIII) reported downbeat results for its fourth quarter.

G-III Apparel posted a Q4 loss of $0.16 per share on revenue of $603.29 million. Analysts were expecting earnings of $0.10 per share on revenue of $622.76 million.

G-III expects FY 2018 earnings of $0.80 to $0.90 per share, and revenue of $2.73 billion. Analysts projected earnings of $1.41 per share on revenue of $2.88 billion.

Equities Trading UP

Cellect Biotechnology Ltd. (NASDAQ: APOP) shares shot up 65 percent to $10.32 after the company disclosed that the first stem cell transplant has been completed in its Phase I/II trial.

Shares of Impax Laboratories Inc (NASDAQ: IPXL) got a boost, shooting up 26 percent to $11.65. Impax named Paul Bisaro as CEO.

Systemax Inc. (NYSE: SYX) shares were also up, gaining 27 percent to $9.15 as the company agreed to sell all of its unprofitable European Technology Products Group businesses.

Equities Trading DOWN

Foamix Pharmaceuticals Ltd (NASDAQ: FOMX) shares tumbled 43 percent to $5.16 after the company reported the topline results of its two Phase 3 trials for FMX101 in patients with moderate-to-severe acne. The company did not demonstrate statistical significance on one of two primary endpoints.

Shares of G-III Apparel Group, Ltd. (NASDAQ: GIII) were down 13 percent to $19.84 after the company reported downbeat results for its fourth quarter and issued a weak forecast.

Sierra Wireless, Inc. (USA) (NASDAQ: SWIR) was down, falling 8 percent to $27.35. Raymond James downgraded Sierra Wireless from Outperform to Market Perform.

Commodities
In commodity news, oil traded down 0.48 percent to $47.74, while gold traded up 0.41 percent to $1,256.80.

Silver traded up 1.62 percent Monday to $18.04, while copper fell 2 percent to $2.58.

Euro zone
European shares were lower today. The eurozone’s STOXX 600 fell 0.44 percent, the Spanish Ibex Index dropped 0.17 percent, while Italy’s FTSE MIB Index declined 0.47 percent. Meanwhile, the German DAX declined 0.66 percent, and the French CAC 40 fell 0.16 percent while UK shares dropped 0.59 percent.

Economics

The Treasury will also auction 2-year notes at 1:00 p.m. ET.

Chicago Federal Reserve Bank President Charles Evans is set to speak in Madrid, Spain at 1:15 p.m. ET.

Dallas Federal Reserve Bank President Dennis Kaplan will speak in College Station, Texas at 6:30 p.m. ET.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today